Or Eisenberg

Or Eisenberg is the current CFO at NeuroSense Therapeutics and has held this position since March 2021. Prior to this, Eisenberg served as the CFO and COO at Wize Pharma from March 2015 to March 2021. Before Wize Pharma, Eisenberg was the owner of O. Eisenberg Accounting Ltd from March 2013 to June 2021 where they provided CPA, accounting, and financial services for small and medium sized businesses. Additionally, Eisenberg has served as the corporate controller at Katzir Fund from October 2010 to December 2014 and as a senior in assurance services at Ernst & Young from October 2007 to October 2010.

Or Eisenberg's educational career began at the University of Haifa, where they earned a Bachelor of Arts in Economics and Accounting. Or then attended the Hebrew Reali School in Haifa, where they earned a degree in accounting.

Their manager is Alon Ben-Noon, Co-Founder & CEO. They are on a team with Oron Yacoby-Zeevi - Chief Scientific Officer, Sharon Cohen Vered - VP, CMC, and Avital Pushett - Head of ALS Clinical Program.